Novel antitumor and radioprotective sulfonamides containing pyrrolo[2,3-d]pyrimidines

Arzneimittel-Forschung/Drug Research

Volumn 56, Issue 6, 2006, Pages 405-413

  Ghorab, Moustafa M ^a   Noaman, Eman ^a   Ismail, Magda M F ^b   Heiba, Helmy I ^a   Ammar, Yousry A ^c   Sayed, Marwa Y ^a  

^a NATIONAL CENTER FOR RADIATION RESEARCH AND TECHNOLOGY   (Egypt)

^b Al Azhar University   (Egypt)

^c Assiut Branch   (Egypt)

Author keywords

Antitumor agents; Pyrrole derivatives, synthesis; Pyrrolo 2,3 d pyrimidine derivatives, synthesis; Radioprotective agents

Indexed keywords

DOXORUBICIN; GLUTATHIONE; PYRIMIDINE DERIVATIVE; PYRROLE (5A C,8,11B 19,23,24); PYRROLO [2,3 B] PYRIDINE; PYRROLO [2,3D] PYRIMIDINE (6,7,10,20,21,25); SULFONAMIDE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; LIPID PEROXIDATION; RADIATION PROTECTION; SPECTROSCOPY;

EID: 33745885943     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296742     Document Type: Article

References (19)

1. Teicher, B. A, Liu, S. D., Liu, J. T. et al., A carbonic anhydrase inhibitor as a potential modulator of cancer therapies, Anticancer Res. 13, 1549 (1993)
2. Supuran, C. T., Scozzafava, A., Carbonic anhydrase inhibitors and their therapeutic potential, Exp. Opin. Ther. Patents 10, 575 (2000)
3. Supuran, C. T., Scozzafava, A., Carbonic anhydrase inhibitors, Curr. Med. Chem. Immunol. / Endocr. Metab. Agents 1, 61 (2001)
4. 7-Substituted-5-aryl- pyrrolo[2,3-d] pyrimidines represent a versatile class of potent inhibitors of tyrosine kinase c-Src, Mini Rev. Med. Chem. 2, 201 (2002)
5. Bennasroune, A., Gardin, A., Aunis, D. et al., Tyrosine kinase receptors as attractive targets of cancer therapy, Crit. Rev. Oncol. Hematol. 50, 23 (2004)
6. Lauderback, C. M., Breier, A. M., Hackett, J. et al., The pyrrolopyrimidine U101033E is a potent free radical scavenger and prevents Fe(II)-induced lipid peroxidation in synaptosomal membranes, Biochem. Biophys. Acta 1501, 149 (2000)
7. Umadedi, P., Solomon, F. E., Sharada, A. C. et al., Plumbagin, a plant naphthoquinone with antitumor and radio-modifying properties, Pharm. Biol. 37, 231 (1999)
8. Brusick, D. J., Cytogenetic assays, aberrations and SCE techniques in carcinogenesis and mutagenesis testing, pp. 265-276, Human Press, Clifton, New Yersey (1984)
9. Osman, A. M., Sayed Ahmed, M. M., Khayyal, M. T. et al., Hyperthermic potentiation of cisplatin on solid Ehrlich carcinoma, Tumori 79, 268 (1993)
10. Yoshioka, T., Kawada, K., Shimada, T. et al., Lipid peroxidation in maternal and cord blood and protective mechanism against activated oxygen toxicity in the blood, Am. J. Obstet. Gynecol. 135, 372 (1979)
11. Beutler, E., Duron, O., Kelly, D. M., Improved method of the determination of blood glutathione, J. Lab. Clin. Med. 61, 882 (1963)
12. Minami, M., Yoshikawa, H., A simplified assay method of superoxide dismutase. Clinica Chemica Acta 92, 337 (1979)
13. Snedecor, G. W., Cochron, W. G, Statistical Methods, 8th ed., Louis State University Press, Ames, Iowa (1989)
14. Sohal, R. S, Weindruch, R., Oxidative stress, caloric restriction and aging, Science 273, 59 (1996)
15. Beckman, K. B, Ames, B. N, The free radical theory of, aging matures, Physiol. Rev, 78, 547 (1998)
16. Bonnetfont, D. R., Irradiation of cell membranes, J. Chim. Phys. Phys. Chim. Biol. 191, 968 (1994)
17. Tenchova, V., Acute gamma irradiation effect on lipid peroxidation and antioxidant activity in rat hemopoietic organs and plasma, Rentgenologiya Radiologiya 33, 49 (1994)
18. Navarro, J., Obrador, E., Carretero, J. et al., Changes in glutathione status and the antioxidant system in blood and in cancer cells associated with tumor growth in vivo, Free Radic. Biol. Med. 26, 410 (1999)
19. Sahu, S. K., Oberley, L. W., Stevens, R. H. et al., Superoxide dismutase activity of Ehrlich ascities tumor cells, J. Natl. Cancer Inst. 58, 1125 (1977)